Form 4 • Statement of Changes in Beneficial Ownership
Type
Neutral
Net shares
+10,723
% of shares
31.77%
Amount (USD)
$0
Insider confidence score
90.0 out of 100
Positive
Negative
Security
Common Stock
Action
Grant
Date
2026-03-03
Code
A
Net shares
+10,723.0
Acquired/Disposed
Acquired
Shares Owned Before
33,755.0
Shares Owned After
44,478.0
1. These shares include 590 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.